45 related articles for article (PubMed ID: 38430269)
1. The future of cryoablation: An abscopal effect.
Chen J; Qian W; Mu F; Niu L; Du D; Xu K
Cryobiology; 2020 Dec; 97():1-4. PubMed ID: 32097610
[TBL] [Abstract][Full Text] [Related]
2. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
3. Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy.
Shen L; Tan H; Nie J; Jiang Y; Nuerhashi G; Qi H; Cao F; Wen C; Chen S; Zhang T; Zheng W; Liu P; Liu Y; Huang T; Li D; Zhang X; Fan W
Cancer Immunol Immunother; 2024 Mar; 73(4):68. PubMed ID: 38430269
[TBL] [Abstract][Full Text] [Related]
4. Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study.
Shen L; Qi H; Chen S; Cao F; Xie L; Wu Y; Ma W; Song Z; Yuan H; Zhang T; Li D; Wen X; Chen Q; Li W; Zhang X; Fan W
Cancer Immunol Immunother; 2020 Sep; 69(9):1713-1724. PubMed ID: 32333081
[TBL] [Abstract][Full Text] [Related]
5. Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer.
Gu C; Wang X; Wang K; Xie F; Chen L; Ji H; Sun J
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272564
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
[TBL] [Abstract][Full Text] [Related]
7. Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Knispel S; Gassenmaier M; Menzies AM; Loquai C; Johnson DB; Franklin C; Gutzmer R; Hassel JC; Weishaupt C; Eigentler T; Schilling B; Schummer P; Sirokay J; Kiecker F; Owen CN; Fleischer MI; Cann C; Kähler KC; Mohr P; Bluhm L; Niebel D; Thoms KM; Goldinger SM; Reinhardt L; Meier F; Berking C; Reinhard R; Susok L; Ascierto PA; Drexler K; Pföhler C; Tietze J; Heinzerling L; Livingstone E; Ugurel S; Long GV; Stang A; Schadendorf D; Zimmer L
Eur J Cancer; 2021 May; 148():61-75. PubMed ID: 33735811
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Shoushtari AN; Munhoz RR; Kuk D; Ott PA; Johnson DB; Tsai KK; Rapisuwon S; Eroglu Z; Sullivan RJ; Luke JJ; Gangadhar TC; Salama AK; Clark V; Burias C; Puzanov I; Atkins MB; Algazi AP; Ribas A; Wolchok JD; Postow MA
Cancer; 2016 Nov; 122(21):3354-3362. PubMed ID: 27533633
[TBL] [Abstract][Full Text] [Related]
9. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract][Full Text] [Related]
10. IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Mallardo D; Simeone E; Festino L; Tuffanelli M; Vanella V; Trojaniello C; Vitale MG; Ottaviano M; Capone M; Madonna G; Sparano F; Cioli E; Scarpato L; Palla M; Di Trolio R; Meinardi P; Caracò C; Ferrara G; Muto P; Cavalcanti E; Ascierto PA
J Transl Med; 2023 Feb; 21(1):140. PubMed ID: 36823670
[TBL] [Abstract][Full Text] [Related]
11. Melanoma metastasis: What role does melanin play? (Review).
Saud A; Sagineedu SR; Ng HS; Stanslas J; Lim JCW
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281942
[TBL] [Abstract][Full Text] [Related]
12. STING-induced regulatory B cells compromise NK function in cancer immunity.
Li S; Mirlekar B; Johnson BM; Brickey WJ; Wrobel JA; Yang N; Song D; Entwistle S; Tan X; Deng M; Cui Y; Li W; Vincent BG; Gale M; Pylayeva-Gupta Y; Ting JP
Nature; 2022 Oct; 610(7931):373-380. PubMed ID: 36198789
[TBL] [Abstract][Full Text] [Related]
13. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity.
Wu Y; Cao F; Zhou D; Chen S; Qi H; Huang T; Tan H; Shen L; Fan W
Front Immunol; 2022; 13():930461. PubMed ID: 36119081
[TBL] [Abstract][Full Text] [Related]
14. Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy.
Li W; Wu Z; Meng W; Zhang C; Cheng M; Chen Y; Zou Y; Li K; Lin S; Xiong W; Wang Y; Lin Y; Ma W; Zhou W
Cytokine; 2022 Oct; 158():155976. PubMed ID: 35921790
[TBL] [Abstract][Full Text] [Related]
15. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
